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The nuclear orphan receptor COUP-TFII is widely expressed in multiple tissues and organs throughout
embryonic development, suggesting that COUP-TFII is involved in multiple aspects of embryogenesis. Because
of the early embryonic lethality of COUP-TFII knockout mice, the role of COUP-TFII during limb development
has not been determined. COUP-TFII is expressed in lateral plate mesoderm of the early embryo prior to limb
bud formation. In addition, COUP-TFII is also expressed in the somites and skeletal muscle precursors of the
limbs. Therefore, in order to study the potential role of COUP-TFII in limb and skeletal muscle development,
we bypassed the early embryonic lethality of the COUP-TFII mutant by using two methods. First, embryonic
chimera analysis has revealed an obligatory role for COUP-TFII in limb bud outgrowth since mutant cells are
unable to contribute to the distally growing limb mesenchyme. Second, we used a conditional-knockout
approach to ablate COUP-TFII specifically in the limbs. Loss of COUP-TFII in the limbs leads to hypoplastic
skeletal muscle development, as well as shorter limbs. Taken together, our results demonstrate that COUP-
TFII plays an early role in limb bud outgrowth but not limb bud initiation. Also, COUP-TFII is required for
appropriate development of the skeletal musculature of developing limbs.
The muscles of the limbs and ventral body wall originate
from the somites, epithelial spheres of paraxial mesoderm that
form in a rostral-to-caudal direction along both sides of the
neural tube (10, 12, 13, 15). The somites give rise to two
separate muscle-forming cell populations. First of all, cells of
the dorsomedial dermomyotome give rise to the epaxial myo-
tome, which eventually develops into the muscles of the back.
These epaxial muscle precursors express MyoD and other mus-
cle-specific proteins and are dependent on signals arising from
the notochord and the floor plate for their differentiation (8,
21, 40, 45, 49). Second, cells of the ventrolateral dermomyo-
tome generate the hypaxial muscle lineage, whose develop-
mental fate is dependent on the rostrocaudal positioning of the
somite. At interlimb levels, the lateral dermomyotome gener-
ates the thoracic and abdominal muscles (14). For somites that
are located adjacent to the limbs, however, the muscle precur-
sor cells of the lateral dermomyotome undergo an epithelial-
mesenchymal transition and migrate to the limbs and dia-
phragm, where they subsequently proliferate and then undergo
differentiation (5, 7, 11, 22). These migrating muscle precur-
sors do not express myogenic determination genes until after
they have reached their targets in the limbs. Although the
signals regulating hypaxial cell specification are not as well
understood, it is believed that signals from the surface ecto-
derm are required for their formation (9, 20, 53, 55).
Once the migrating muscle precursor cells reach the limbs,
they populate the dorsal and ventral mesenchyme as two pre-
muscular masses. These premuscular masses consist of two
parts, a surface layer of proliferating muscle precursor cells
and a deeper layer of differentiating myoblasts that express
myogenic differentiation markers such as myogenin. These two
populations strike a balance between proliferation and differ-
entiation (42) such that any increase in proliferation leads to
an increase in muscle size. However, if terminal differentiation
is induced prematurely, there has not been enough time for
adequate proliferation to occur and the result is smaller mus-
cles (28). This balancing act is mediated by the activity of
several signals. An increase in the proliferative pool can be
induced by FGFs, IGFI, and BMPs, whereas a decrease in
muscle mass can be achieved through the use of BMP antag-
onists such as noggin (1, 4, 26, 31). Furthermore, activation of
the Notch pathway has been shown to cause muscle precursor
cells to continue to express Pax3 and Myf5, downregulating
MyoD and thereby preventing the onset of terminal differen-
tiation (17). Recently, Sonic hedgehog (SHH) has been dem-
onstrated to play a role in limb skeletal muscle size by acting as
a survival and proliferation factor. Loss of SHH activity results
in hypoplastic limb muscles, whereas ectopic overexpression in
the chick is able to cause muscle hypertrophy, possibly by
upregulating the BMP pathway (2, 23, 37).
Chicken ovalbumin upstream promoter transcription factor
II (COUP-TFII) is a nuclear orphan receptor of the steroid-
thyroid hormone receptor superfamily (57). COUP-TFII is
most highly expressed during embryonic development, and
mutation of this gene results in early embryonic lethality be-
cause of defects in angiogenesis and heart development (43,
44, 47). Previous study of cell cultures has indicated a role for
COUP-TFII in muscle development by showing that COUP-
TFII inhibits the expression and transcriptional function of
MyoD, thereby preventing muscle differentiation (3, 41). Fur-
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thermore, COUP-TFII lies downstream of SHH signaling and
may therefore be a mediator of the SHH pathway in certain
developmental situations (35, 36). Although COUP-TFII is
well defined biochemically, its physiological functions during
embryogenesis remain largely undefined. This is in large part
because of the fact that the COUP-TFII mutant is an early
embryonic lethal mutant that dies prior to E10 because of
angiogenesis and cardiovascular failure, preventing the study
of the role of COUP-TFII in the development of tissues and
organs at later stages. In this study, we addressed the function
of COUP-TFII during embryonic limb development. We used
both embryonic chimera and tissue-specific knockout tech-
niques to bypass the early embryonic lethality of the COUP-
TFII knockout. By embryonic chimera analysis, we demon-
strated that COUP-TFII is required for mesenchymal cells to
contribute to the distally growing limb bud in chimeric em-
bryos. In addition, tissue-specific knockout of COUP-TFII in
the limb bud results in hypoplastic musculature. Therefore,
COUP-TFII is required for limb bud outgrowth and proper
limb muscle development.
MATERIALS AND METHODS
Generation of stable ES cell lines. Stable embryonic stem (ES) cell lines
homozygous for the COUP-TFII mutation were generated and marked with the
ubiquitously expressed ROSA26-LacZ allele (27), and COUP-TFII/ mice were
naturally mated with COUP-TFII/ ROSA26/ mice (mixed 129Sv-C57BL/6
background). Blastocysts were then isolated by flushing the uterine horns of
pregnant females at embryonic day 3.5 (E3.5), where the day of vaginal plug
detection is designated E0.5. Uteri were flushed with sterile ES medium (high-
glucose Dulbecco modified Eagle medium, 15% fetal calf serum, 1% L-glu-
tamine, 0.5% penicillin-streptomycin, 0.18% -mercaptoethanol) supplemented
with 0.02 M HEPES. Blastocysts were then transferred onto a 60-mm-diameter
tissue culture dish containing a feeder layer of mitotically inactivated SNL cells
in ES medium and allowed to adhere and grow for approximately 4 to 6 days at
37°C in 5% CO2. Once the inner cell mass outgrowth had reached an appropriate
size (large colonies but prior to any cell death or differentiation), colonies were
picked and disaggregated first by treatment with 0.25% trypsin–EDTA and then
pipetting up and down. Disaggregated colonies were plated into individual wells
of a feeder layer-coated 24-well dish. Cells were fed with new medium daily and
passed 1:1 every 3 days to a new well until ES cells became apparent. ES cell lines
were genotyped by PCR for COUP-TFII and by PCR and -galactosidase (-gal)
staining for LacZ. ES cell lines were also karyotyped for normal chromosome
complement as described by Hogan et al. (32). Both wild-type control and
mutant ES cell lines were generated in this fashion.
Generation of chimeric embryos. ES cells were plated and grown until they
reached 90% confluency; they were then passed 1:3 one time until they reached
90% confluency once again prior to trypsinization and resuspension in injection
medium (ES medium) before being placed on ice. After 30 min, most SNL feeder
cells and debris have settled to the bottom of the tube. E3.5 C57BL/6 blastocysts
were flushed out of uteri with injection medium. Malformed or early stage
embryos were sorted out, and the remaining mature blastocysts were washed in
M2 medium. Twelve to 14 ES cells were microinjected into the blastocoels of the
embryos. After all of the embryos had been microinjected, they were transferred
into the uteri of day 2.5 pseudopregnant ICR foster mothers at no more than 10
embryos per uterine horn. Subsequently, embryos were dissected at mid-gesta-
tional stages for 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-Gal)
staining and analysis. Embryonic age was determined by the uterine age of the
foster mothers.
-Galactosidase staining of embryos. Embryos were dissected into cold 1
phosphate-buffered saline (PBS; Gibco) and fixed in 2% paraformaldehyde
(PFA; Sigma) in 1 PBS–0.125 M piperazine-N,N-bis(2-ethanesulfonic acid)
(PIPES; pH 6.9)–1 mM MgCl2–5 mM EGTA (pH 8.0) for 15 to 45 min at room
temperature, depending on the size of the embryo (E9.5 to E12.5, respectively).
Embryos were then washed three times with PBS for 20 min each time. Embryos
were stained in 2 mM MgCl2–0.01% deoxycholate–0.02% NP-40–100 mM phos-
phate buffer (pH 8.0)–5 mM K4Fe(CN)6–5 mM K3Fe(CN)6–1 mg of X-Gal per
ml. After staining, embryos were washed in PBS and stored in 4% PFA at 4°C.
Whole-mount in situ hybridization. Whole-mount in situ hybridization was
performed with probes to myogenin (from Eric Olson) and Lbx1 (from Krzysztof
Jagla) as templates for the generation of digoxigenin-labeled antisense ribo-
probes. The protocols used were essentially the same as those published previ-
ously (46, 48).
Immunohistochemical staining. Embryos were fixed in 2% PFA–PBS (pH 7.4)
for 1 h, cryoprotected in 30% sucrose–PBS (overnight, 4°C), and frozen in PBS
containing 15% sucrose and 7.5% gelatin. Frozen tissues were sectioned at a
thickness of 10 m in a cryostat. The sections were air dried for 1 h at room
temperature and stored at 20°C until used.
The air-dried sections were washed in PBS and incubated in blocking buffer
(PBS, 1% bovine serum albumin, 5% serum, 10 g of Fab fragment donkey
anti-mouse IgG [heavy and light chains] per ml, 0.02% Triton X-100) for 30 min
prior to incubation with the primary antibody (monoclonal anti-Pax3 [1:500;
DSHB], anti-COUP-TFII [1:5,000; kindly provided by Toshiya Tanaka, Depart-
ment of Molecular Biology and Medicine, The University of Tokyo], or mono-
clonal anti-phospho-histone H3 [1:200; Cell Signaling Technology]) overnight at
4°C. After being washed three times with PBS, the sections were incubated with
biotin-SP-conjugated donkey anti-mouse IgG (heavy and light chains; Jackson
ImmunoResearch Laboratories) for 60 min at room temperature. Antibody
binding was visualized with TSA kit no. 22 (Molecular Probes) in accordance
with the manufacturer’s recommendation.
For double immunostaining, the sections were first incubated with the diluted
first primary antibody, monoclonal anti-COUP-TFII (1:5,000) as described above
and staining was amplified with TSA kit no. 22. Subsequently, sections were
incubated with the monoclonal anti-Pax3 second primary antibody and visualized
by conventional fluorescent staining. Briefly, upon completion of the first immu-
nostaining of COUP-TFII, the sections were treated with the blocking buffer for
30 min and then incubated with anti-Pax3 antibody overnight at 4°C. Antibody
binding was visualized with the Cy3-conjugated donkey anti-mouse IgG (heavy
and light chains; Jackson ImmunoResearch Laboratories) secondary antibody.
RESULTS
Expression of COUP-TFII indicates a role in limb and mus-
cle development. To determine the function of COUP-TFII
during embryonic limb development, we began by examining
the tissue-specific expression pattern of the COUP-TFII gene.
This was done by using a LacZ knock-in mouse generated in
our laboratory, in which a nuclear LacZ gene was used to
replace the COUP-TFII gene, thereby being expressed under
the control of the COUP-TFII regulatory region (56). There-
fore, the expression of COUP-TFII during limb development
was monitored in heterozygotes by measuring -gal activity by
X-Gal staining. When E9.5 embryos were stained with X-Gal,
it was found that COUP-TFII was expressed in the lateral plate
mesoderm (LPM) from the earliest stages of limb bud initia-
tion and outgrowth (Fig. 1A). Since the embryonic limb is
initiated and first appears as an outgrowth of the LPM around
early E9 (33, 58), this expression suggests that COUP-TFII has
an important function during early limb bud development,
either during limb bud initiation itself or in events following
induction of the limb bud.
Interestingly, COUP-TFII is also expressed in the embryonic
somites. COUP-TFII expression in the somites begins at E8.5
(data not shown) and can be clearly seen by E9.5 (Fig. 1B).
This expression in the somites suggests that COUP-TFII plays
a role in muscle development. At the limb levels, COUP-TFII
is highly expressed throughout both the myotome and the
dermomyotome of the developing somites (Fig. 1C). There-
fore, it is possible that COUP-TFII functions in both epaxial
and hypaxial lineages of somite-derived muscle cells (11, 22).
First, its expression in the myotome suggests that COUP-TFII
is important for development of the muscles of the body
proper, including the intercostal muscles, abdominals, and tho-
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racic muscles. Second, its expression in the ventrolateral der-
momyotome at limb levels suggests a role in the migrating
hypaxial muscle lineage, which consists of cells that migrate
from the somites to form the muscles of the limbs and dia-
phragm (7, 11, 20, 22, 52).
This expression pattern in muscle precursor cells persists in
older embryos. At E10.5, COUP-TFII is still highly expressed
in the somites (Fig. 1D). However, COUP-TFII is no longer
expressed throughout the mesenchyme as it is at E9.5, but
rather it is expressed in the fore and hind limb buds in a
centralized core of the mesenchyme (Fig. 1E). Cross sections
of these limbs demonstrate that COUP-TFII is expressed in
two distinct centralized mesenchymal masses (Fig. 1F). One of
these masses is located in the dorsal half of the limb, and the
other is located in the ventral half. This expression pattern is
highly reminiscent of the location of the dorsal and ventral
premuscle masses, which are groups of mesenchymal tissue
that eventually differentiate into the skeletal muscle elements
of the limbs (11). Additionally, COUP-TFII is expressed in the
apical ectodermal ridge (AER) at this age (Fig. 1F; also E11.5,
in Fig. 1H). By E11.5, COUP-TFII is still expressed in the
myogenic mesenchyme (Fig. 1G), and by E12.5, COUP-TFII is
expressed in the individual differentiating muscle bundles of
both the fore and hind limbs (Fig. 1J, K, and L). COUP-TFII
also appears to be expressed in other mesenchymal tissues,
which are not associated with developing muscle at both E11.5
and E12.5.
COUP-TFII is required for somitic myogenesis. On the basis
of the somitic expression of COUP-TFII in the myotomes and
limb level dermomyotomes, we hypothesized that COUP-TFII
may play a role in embryonic muscle development. To deter-
mine if COUP-TFII plays a role in hypaxial muscle precursor
cell migration, we analyzed COUP-TFII null mutants for the
expression of Lbx1, a hypaxial lineage marker (30). Whole-
mount in situ hybridization for Lbx1 in both wild-type and
COUP-TFII null mutant embryos shows positively expressing
cells in both the somites and the limbs, but at a slightly reduced
level in COUP-TFII mutant embryos (Fig. 2A and B). This
result suggests that muscle precursor cells are able to migrate
to the limb but may be at a reduced level.
Next, we examined the expression of the myogenic determi-
nation factor myogenin in wild-type and COUP-TFII mutant
embryos in order to determine if COUP-TFII plays a role in
myogenic differentiation. Since COUP-TFII mutants are em-
bryonic lethal prior to E10 (44), we analyzed E9.5 embryos at
FIG. 1. Expression of COUP-TFII. (A and B) Whole-mount X-Gal
staining of E9.5 embryos. COUP-TFII is expressed in the LPM (arrow
and box in panel A) and somites (arrowheads in panel B). (C) Cross
section of X-Gal-stained E9.5 embryos. At limb levels, COUP-TFII is
expressed in the myotome and lateral dermomyotome, which gives rise
to migrating muscle precursors (arrow). (D and E) Whole-mount X-
Gal staining of E10.5 embryos. COUP-TFII is still expressed in somites
(arrowheads in panel D) and becomes expressed in the dorsal and
ventral muscular masses in the limb, as well as in the AER. (F) Cross
section of X-Gal-stained E10.5 embryo. COUP-TFII is expressed in the
myotomes and dorsal and ventral muscle masses, as well as the AER
(arrowhead). (G and H) Whole-mount X-Gal staining of E11.5 em-
bryos. COUP-TFII is expressed in somites (arrowheads in panel G), in
premuscular masses (arrows in panel G), and in the AER (arrow in
panel H). (I) Cross section of an X-Gal-stained E11.5 embryo. COUP-
TFII is expressed in premuscle masses, as well as in other mesenchymal
tissues of the limb. (J) Whole-mount X-Gal staining of an E12.5
embryo. COUP-TFII is expressed in the developing muscle bundles
(arrow). (K and L) Frontal sections of fore and hind limbs of X-Gal-
stained embryos at E12.5. Expression of COUP-TFII can be clearly
seen in individual muscle bundles (arrows) and nonmuscle mesen-
chyme. Abbreviations: M, myotome; DM, dermomyotome; DMM,
dorsal myogenic mass; VMM, ventral myogenic mass.
FIG. 2. Expression of marker genes for muscle migration and mus-
cle differentiation. (A and B) Whole-mount in situ hybridization of
E9.5 wild-type and mutant embryos for Lbx1. Lbx1 expression is de-
tected in both somites and limbs of COUP-TFII embryos, indicating
that muscle precursor cells are able to migrate into the limbs. (C and
D) Whole-mount in situ hybridization of wild-type and COUP-TFII
mutant embryos for myogenin. Expression of myogenin is significantly
decreased in caudal somites of COUP-TFII mutant embryos compared
to that in wild-type embryos (arrowheads).
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the 22-somite stage of development by whole-mount in situ
hybridization. myogenin expression in COUP-TFII mutant em-
bryos is significantly lower than in wild-type embryos of the
same age (Fig. 2C and D). Although myogenin is still expressed
in the mutant embryos, it does not extend as far in the caudal
axis as in wild-type embryos and the level of myogenin expres-
sion is much reduced at the caudal end. This indicates that
COUP-TFII is important for muscle development and suggests
that either COUP-TFII is directly involved in the myogenic
differentiation pathway or that, in the absence of COUP-TFII,
there are fewer differentiating muscle cells.
Chimera analysis reveals an early cell-autonomous role for
COUP-TFII in limb bud outgrowth. On the basis of the COUP-
TFII expression pattern in limbs, we examined the role of
COUP-TFII during limb development. To circumvent the
early lethality of our mutant, we used an embryonic chimera
approach (50). This approach consists of microinjecting wild-
type or COUP-TFII mutant ES cells into wild-type blastocysts
in order to generate chimeric embryos that are composed of a
mixture of ES cell-derived and blastocyst-derived cells (32, 34).
Since the ES cells were derived from mice containing the
ubiquitously expressed ROSA26-LacZ transgene (27), they can
be differentiated from the wild-type blastocyst-derived cells by
detecting -gal enzyme activity with X-Gal.
With two independently generated mutant ES cell lines,
chimeric embryos were stained for -gal enzyme activity. The
percent chimerism of each embryo was visually estimated by
examining sections of each embryo for the extent of X-Gal
staining. Five mutant chimeras composed of greater than 50%
mutant cells analyzed at E10.5 show a distinct white patch at
the distal end of the limb bud (Fig. 3A), while chimeric em-
bryos generated with wild-type ES cells show an even distribu-
tion of X-Gal-positive tissue (Fig. 3D). This result indicates
that the mutant cells are not able to maintain contribution to
the limb bud and demonstrates that COUP-TFII has a cell-
autonomous function during limb development. By E11.5 and
E12.5, it is very clear that COUP-TFII mutant cells are unable
to contribute to the limb bud, since virtually the entire limb is
devoid of blue-staining mutant cells by these ages (Fig. 3B and
C). In contrast, wild-type cells have no difficulty populating the
entire limb bud at E11.5 and E12.5 (Fig. 3E and F). This
suggests that COUP-TFII has a critical cell-autonomous func-
tion during limb bud outgrowth.
To analyze this phenotype further, we examined cross sec-
tions of chimeric limbs and found that while COUP-TFII mu-
tant cells are initially able to contribute to the early stages of
limb bud initiation and outgrowth at E9.5 (Fig. 3G), COUP-
TFII mutant cells do begin to restrict from the very distal tip of
the limb bud. By E10.5, the mutant cells are absent from
approximately half of the limb bud, and by E11.5 only scattered
mutant cells are present in the limb (Fig. 3H and I). In con-
trast, wild-type ES cell-derived cells can contribute to the
whole limb at all of the stages examined without any obvious
deficiencies (Fig. 3J to L). These results suggest that COUP-
TFII is not required for limb bud initiation, since the early limb
bud still contains COUP-TFII mutant cells. Rather, it is more
likely that COUP-TFII plays an important, cell-autonomous
role in later stages of limb bud outgrowth. This observation is
consistent with the fact that the conventional COUP-TFII
knockout, which is embryonic lethal prior to E10, still displays
an early limb bud. Interestingly, COUP-TFII also appears only
to be required cell autonomously for contribution to the limb
mesenchyme, since both the surface ectoderm of the limb and
the AER still contain COUP-TFII mutant cells (arrowhead in
Fig. 3H).
Conditional ablation of COUP-TFII in limbs reveals a hy-
poplastic-muscle phenotype. To further assess the function of
COUP-TFII in limb outgrowth, the Cre/loxP system was used
to ablate COUP-TFII in the limbs. We have generated an allele
of COUP-TFII in which the COUP-TFII locus is flanked by
loxP sites (COUP-TFIIflox) (56). Upon exposure to the Cre
recombinase enzyme, the COUP-TFII coding region is excised
and replaced with a LacZ reporter gene, which is then ex-
pressed under the control of the COUP-TFII regulatory region.
Consequently, tissue-specific deletion of the COUP-TFII gene
in cells that normally express COUP-TFII can be identified by
X-Gal staining. To generate a limb-specific knockout of
COUP-TFII, we used the Prx1-Cre transgenic mouse. This
mouse contains a transgenic Cre recombinase gene under the
control of the Prx1 enhancer, which directs Cre expression
specifically throughout the limb bud mesenchyme, body wall
tissue, and some craniofacial mesenchyme (38). When this
strain was crossed with our COUP-TFIIflox mice (Fig. 4A and
B) or with ROSA reporter mice (54; data not shown), staining
for -gal activity demonstrated that recombination occurs spe-
FIG. 3. COUP-TFII is required cell autonomously in limb mesen-
chyme. Whole-mount X-Gal staining (A to F) and cross sections of
X-Gal-stained chimeric embryos (G to L). (A to C) Chimeric embryos
restrict mutant cells progressively starting at E10.5, as shown by the
white patches visible in chimeric E10.5 limbs (arrow in panel A) and
the almost completely white limbs at E11.5 and E12.5 (arrows in panels
B and C). (D to F) Wild-type chimeras do not have restriction of ES
cell-derived cells from the limbs (arrows), which are uniformly blue. (G
to I) Cross sections of X-Gal-stained mutant chimeras show that ex-
clusion of mutant cells begins at E9.5 (arrow in panel G) and is largely
complete by E12.5. Mutant cells are able to contribute to the AER
(arrowhead in panel H). (J to L) Wild-type ES cell-derived cells are
able to contribute to the limbs at all stages.
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cifically in the limb bud (Fig. 4A and B). The recombination
induced by the Prx1-Cre transgene is initiated around E9.5 in
the forelimb and is not completed until E10.5. In the hind limb
at E9.5, however, Cre recombinase activity was only detected
in a few scattered cells (Fig. 4A).
When embryos containing the Prx1-Cre transgene and
COUP-TFIIflox alleles were analyzed, we observed that while
patterning and other general developmental features appeared
to be unaffected, the mutant limbs were almost always notice-
ably shorter than those of their controlled littermates (Prx1-Cre
or COUP-TFIIflox). This first appeared distinctively at E12.5
and was particularly obvious at E15.5 (Fig. 4C), when the
mutant limb was approximately 85% of the length of that of the
wild-type littermate. When these embryos were stained for
skeletal preps, however, it appeared that all of the skeletal
elements were intact (data not shown). Consequently, we be-
lieve that COUP-TFII may play a role in limb outgrowth, and
this may reflect a function of the early expression of COUP-
TFII in the LPM at E9. Since recombination of COUP-TFIIflox
did not take place until E9.5, at a time when COUP-TFII is
already expressed, the incomplete excision of COUP-TFII dur-
ing this critical time period may contribute to the partial short-
ening of the limbs seen at later ages. Although there was
shortening of the forelimbs, there was no defect in the hind
limbs of the conditional knockouts at any of the embryonic
development stages; this may have been due to the low Cre
recombinase activity in the hind limbs of the Prxl-Cre mice used
(Fig. 4A).
To analyze whether COUP-TFII plays a role in the devel-
opment of the skeletal muscle elements of the limbs, we began
by looking at the expression of the differentiation marker myo-
genin by in situ hybridization. At E10.5, myogenin is expressed
in the somitic myotomes, as well as in the mesenchyme of the
limb buds. In the limb-specific knockout embryos, myogenin
was clearly expressed in the limb buds at this age and there
appeared to be no detectable difference in expression between
the limb-specific COUP-TFII knockout mutant (Fig. 5B) and
control (Fig. 5A) embryos. By E11.5, however, the myogenin
expression pattern was distinctively altered in the mutants (Fig.
FIG. 4. Conditional mutation of COUP-TFII in the limb. (A) Whole-
mount X-Gal staining of embryos derived by crossing Prx1-Cre mice with
COUP-TFIIflox mice. Significant recombination has occurred in the fore-
limb at E9.5, but few cells are recombined in the hind limb. (B) Histo-
logical sections of an embryo identical to that in Fig. 5A show a high
percentage of recombination in the forelimb at this age. (C) Conditional-
mutant forelimbs at E15.5 are shorter than those of a wild-type littermate,
although individual limb elements appear to be appropriately specified.
The bar approximately brackets the limb between the shoulder and the tip
of the digits. Abbreviations: fl, forelimb; hl, hind limb; Cond. KO, condi-
tional knockout.
FIG. 5. Loss of COUP-TFII leads to hypoplastic muscles. (A and B)
Whole-mount in situ hybridization for myogenin of control and condi-
tional-knockout (Cond. KO) embryos at E10.5. There is no significant
difference in expression (arrows) between control and conditional-
knockout embryos. (C and D) Whole-mount in situ hybridization for
myogenin of control and conditional-knockout embryos at E11.5. The
region of myogenin expression does not extend as far distally in the
conditional-knockout embryo as in the control embryo (arrows). (E to
H) Trichrome staining of frontal sections of an E17.5 forelimb. Com-
pared to that of control embryos at E17.5 (E and G), conditional-
knockout limb bud musculature is hypoplastic and reduced in size (F
and H). Although most individual muscle bundles appear to be appro-
priately specified, they are significantly smaller (arrows).
VOL. 24, 2004 COUP-TFII IS REQUIRED FOR LIMB AND MUSCLE DEVELOPMENT 10839
 o
n
 Septem
ber 12, 2018 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
5D) in comparison with that in the control (Fig. 5C). At this
embryonic age, what was initially a solid mesenchymal core of
differentiating muscle has begun to segregate into separate
muscle bundles expressing myogenin. When mutant embryos
were examined and compared to control littermates, it was
clear that the mutant limb bud contained muscle bundles that
did not extend distally to the same extent as in the control (Fig.
5C and D). This result was observed consistently in multiple
experiments and strongly suggests that COUP-TFII is required
for appropriate development of the limb musculature.
When the limb-specific mutant embryos were examined his-
tologically, it was found that the mutant limb buds had under-
developed, hypoplastic musculature. This first became evident
as early as E12.5 but became particularly pronounced by E17.5
(Fig. 5E to H). Both wild-type and mutant E17.5 fore limbs
were sectioned frontally and compared to each other, and the
FIG. 6. Cell migration and proliferation. (A to C) Transverse sections through the forelimbs of E10.5 wild-type embryos stained with antibodies
to detect COUP-TFII (green) and Pax3 (red). Pax3-expressing cells are seen delaminating from the dermomyotome, and migrating muscle
precursors coexpress Pax3 and COUP-TFII. (D to K) Transverse sections through the forelimbs of E9.5 (D to G) and E10.5 (H to K) control
embryos (D, E, H, and I) and conditional-knockout littermates (F, G, J, and K) stained with antibody Pax3 (green) and 4,6-diamidino-2-
phenylindole (DAPI) (blue). (L to O) Transverse section through the forelimbs of an E9.5 control embryo (L and M) and a conditional-knockout
littermate (N and O) stained with antibody for phospho-histone H3 (green) and DAPI (blue). (P and Q) Frontal sections of the forelimbs of an
E14.5 control embryo (P) and a conditional-knockout littermate (Q) stained with antibody for phospho-histone H3 (green).
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individual muscle bundles of the mutant embryos were drasti-
cally smaller and less well developed. The diameters of the
developing bones, however, appeared relatively unchanged.
Interestingly, it appeared that all of the individual muscle bun-
dles were present, indicating that COUP-TFII does not play a
role in the patterning or specification of muscle tissue. Rather,
all of the muscle bundles were hypoplastic in the mutant,
suggesting that COUP-TFII is required for the establishment
of muscle bundles of the appropriate size.
In order to understand the mechanism underlying the role
that COUP-TFII plays in limb development, we carried out
marker analysis to determine whether COUP-TFII plays a role
in muscle precursor cell proliferation and migration. Previous
RNA in situ analyses of Lbx1 expression showed that Lbx1 is
expressed in the ventral dermomyotome at the limb levels in
presumptive migratory muscle precursors, and there is a re-
duction of Lbx1 expression in COUP-TFII mutant embryos
(Fig. 2A and B). This result raises the possibility that COUP-
TFII is involved in muscle precursor cell migration. To support
this hypothesis, it is important to demonstrate that COUP-TFII
is coexpressed in the same precursor cells as the myogenic
precursor cell marker Pax3. Therefore, the expression of
COUP-TFII and Pax3 was examined in wild-type embryos at
E10.5 by immunohistochemistry. The COUP-TFII antibody
detected high COUP-TFII expression in the limb and the ad-
jacent mesenchymal cells (Fig. 6A). Specific Pax3 antibody
detected Pax3 expression in the dorsal neural tube, in dorsal
root ganglia, in dermomyotomes (data not shown), and in
scattered cells in the forelimb (Fig. 6C). Most importantly, all
positively Pax3-stained cells in the forelimb coexpressed
COUP-TFII (Fig. 6B). Therefore, COUP-TFII is expressed in
the myogenic precursor cells and may play a role in muscle
precursor cell migration.
Next, we analyzed the muscle precursor cell migration in the
conditional knockouts and the control littermate embryos by
Pax3 immunostaining. We observed a migration defect in the
conditional knockouts at E9.5 and E10.5 (Fig. 6F and J) in
which the Pax3-positive cells did not extend as far into the limb
axis as in the control embryos (Fig. 6D and H). However, the
observed migration defect in the conditional knockouts was no
longer detected at later stages (i.e., E11.5 or later; data not
shown). This suggested that ablation of COUP-TFII delays
early muscle precursor cell migration and contributes partly to
the defects observed.
To delineate the other factor contributing to the limb defect of
the COUP-TFII mutant, we analyzed the proliferation activity of
control and conditional-knockout embryos at different develop-
mental stages by phospho-histone H3 immunostaining (a mitotic
index marker). We found no significant difference in the prolif-
eration index between control (Fig. 6L) and conditional-knockout
(Fig. 6N) embryos at E9.5, while a reduction in the mutant (Fig.
6Q) compared to the controls (Fig. 6P) was observed later, at
E14.5. Thus, a reduction in cell proliferation in conditional knock-
outs is likely also responsible for the observed shorter-limb phe-
notype in addition to delayed migration.
DISCUSSION
The nuclear orphan receptor COUP-TFII is highly expressed
in multiple tissues throughout embryonic development. In this
study, we have investigated the role of COUP-TFII in limb bud
outgrowth and muscle development. COUP-TFII is expressed
throughout the LPM of the limb field prior to limb bud initi-
ation and then becomes highly expressed in the early limb
mesenchyme. In embryonic chimera analyses, COUP-TFII mu-
tant cells are initially able to contribute to the early stages of
limb bud development, but at later ages they become progres-
sively restricted from the distally growing limb bud mesen-
chyme. This shows that COUP-TFII mutant cells are unable to
successfully compete against wild-type cells in a chimeric en-
vironment during limb bud outgrowth. Furthermore, tissue-
specific ablation of COUP-TFII in the developing limb bud
mesenchyme also results in shorter limbs, providing additional
evidence to support a role for COUP-TFII in limb bud out-
growth. Therefore, COUP-TFII is important for limb bud out-
growth but not limb bud initiation.
To determine whether the shorter limb is caused by more
cell death in conditional knockouts, we did terminal de-
oxynucleotidyltransferase-mediated dUTP-biotin nick end la-
beling staining (29); however, we did not detect any significant
difference between the conditional knockouts and the controls
by this assay at any stage of development (data not shown).
This suggests that the shorter limbs in the conditional-knock-
out mutant are not due to cell death. Similarly, analysis of
COUP-TFII conditional-knockout embryos at E9.5 has failed
to show any significant difference in proliferation compared to
that in the littermate control embryos. However, at later ages
it becomes obvious that the mesenchyme of limbs lacking
COUP-TFII proliferates at a lower rate than in wild-type em-
bryos. This further suggests that COUP-TFII is not involved in
limb bud initiation but rather is required for the maintenance
of limb bud outgrowth. Similar findings have been reported for
the FGF signaling pathway. Loss of FGFR1 or its downstream
effector Shp2 also leads to defects in limb bud outgrowth (18,
51). Interestingly, loss of FGFR1 also leads to hypoplastic
muscles (25), establishing a link between the two developmen-
tal processes. FgfR1 expression, however, does not appear to
be significantly altered in our mutant, nor does the AER-
specific growth factor Fgf8 (data not shown).
In the absence of COUP-TFII, myogenesis does not proceed
normally. Expression of myogenin is reduced in the somites at
the caudal end of COUP-TFII mutant embryos. It appears that
COUP-TFII is involved in hypaxial muscle precursor cell mi-
gration since there is a decrease in the expression of Lbx1 in
the COUP-TFII null mutant at E9.5. The muscle precursor cell
migration defects are also observed in limb buds of the condi-
tional knockout at E9.5 and E10.5 by immunostaining with
Pax3 antibody. Both Lbx1 and Pax3 are markers of hypaxial
muscle precursor cell migration (6, 16, 19, 24, 39). In addition,
the muscles of the limbs fail to develop to the appropriate size
when COUP-TFII is specifically ablated in the limb mesen-
chyme. This defect in muscle development is reflected by the
altered expression of the myogenic differentiation gene myo-
genin in both somitic and limb muscle lineages. This phenotype
is manifested as a reduction in muscle size, although it appears
that all of the individual muscle bundles of the limb are ap-
propriately specified and develop in their proper positions.
Consequently, it appears that COUP-TFII is not involved in
the patterning or specification of the limb muscle but may be
involved in the maintenance or expansion of the muscle lin-
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eage. In addition, COUP-TFII is required for the appropriate
migration of limb muscle precursor cells from the somites to
the limb buds. Since other genes known to be involved in
muscle cell migration are still expressed in the COUP-TFII
mutant, this suggests that COUP-TFII may be involved in a
novel pathway of muscle cell migration that has not previously
been described. It is important to analyze this defect in the
future.
A current model of myogenesis proposes that a balance
between muscle growth and differentiation must be maintained
in order for proper muscle development to occur (28, 42).
COUP-TFII has been shown in cell culture to inhibit both the
expression and the posttranscriptional regulation of MyoD (3,
41), which is required to initiate the myogenic program, which
inevitably causes muscle precursor cells to exit the cell cycle
and differentiate. It is therefore conceivable that COUP-TFII
is required to inhibit muscle differentiation, thereby maintain-
ing the pool of undifferentiated cells. Furthermore, a recent
study suggests that the mitogen SHH is required for repression
of the differentiation of myoblasts in order to stimulate their
proliferation. Without SHH, the myoblasts differentiate pre-
cociously, which eliminates the pool of proliferating myoblasts,
leading to less muscle (37). Our laboratory has previously
demonstrated that COUP-TFII lies downstream of SHH sig-
naling in vitro (35, 36). Furthermore, we have recently shown
that COUP-TFII may act as an effector of SHH signaling in
vivo in the development of the stomach (56). Consequently, it
is conceivable that COUP-TFII lies downstream of SHH to
function in the maintenance and expansion of muscles by in-
hibiting terminal myogenesis.
In conclusion, we have established critical roles for COUP-
TFII in limb and muscle development. COUP-TFII is required
for the distal outgrowth of embryonic limbs and also for ap-
propriate embryonic muscle development. COUP-TFII is re-
quired for the maintenance of proliferation in the growing limb
bud, as well as the migration of muscle precursor cells to the
limbs. COUP-TFII represents a novel player in this complex
field, and it will be exciting to further define the exact molec-
ular pathways in which COUP-TFII functions.
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